Postprandial and Fasting Hepatic Glucose Fluxes in Longstanding Type 1 Diabetes
- Michaela Kacerovsky1,
- John Jones2,3,
- Albrecht I. Schmid1,4,
- Cristina Barosa2,
- Angelika Lettner1,
- Gertrud Kacerovsky-Bielesz1,5,
- Julia Szendroedi1,5,6,7,
- Marek Chmelik1,4,
- Peter Nowotny6,
- Visvanathan Chandramouli8,
- Michael Wolzt9 and
- Michael Roden1,5,6,7⇓
- 1Karl-Landsteiner Institute for Endocrinology and Metabolism, Vienna, Austria
- 2Department of Life Sciences and Center for Neurosciences and Cell Biology, University of Coimbra, Coimbra, Portugal
- 3Portuguese Diabetes Association, Rua do Salitre, Lisbon, Portugal
- 4MR Center of Excellence, Medical University of Vienna, Vienna, Austria
- 51st Medical Department, Hanusch Hospital, Vienna, Austria
- 6Institute for Clinical Diabetology, German Diabetes Center (Leibniz Center for Diabetes Research), Düsseldorf, Germany
- 7Department of Metabolic Diseases, Heinrich-Heine University and University Clinics Düsseldorf, Düsseldorf, Germany
- 8Department of Medicine, University Hospitals Case Medical Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio
- 9Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
- Corresponding author: Michael Roden, .
OBJECTIVE Intravenous insulin infusion partly improves liver glucose fluxes in type 1 diabetes (T1D). This study tests the hypothesis that continuous subcutaneous insulin infusion (CSII) normalizes hepatic glycogen metabolism.
RESEARCH DESIGN AND METHODS T1D with poor glycemic control (T1Dp; HbA1c: 8.5 ± 0.4%), T1D with improved glycemic control on CSII (T1Di; 7.0 ± 0.3%), and healthy humans (control subjects [CON]; 5.2 ± 0.4%) were studied. Net hepatic glycogen synthesis and glycogenolysis were measured with in vivo 13C-magnetic resonance spectroscopy. Endogenous glucose production (EGP) and gluconeogenesis (GNG) were assessed with [6,6-2H2]glucose, GP flux (GP), and gluconeogenic fluxes with 2H2O/paracetamol.
RESULTS When compared with CON, net glycogen synthesis was 70% lower in T1Dp (P = 0.038) but not different in T1Di. During fasting, T1Dp had 25 and 42% higher EGP than T1Di (P = 0.004) and CON (P < 0.001; T1Di vs. CON: P = NS). GNG was 74 and 67% higher in T1Dp than in T1Di (P = 0.002) and CON (P = 0.001). In T1Dp, GP flux (7.0 ± 1.6 μmol ⋅ kg−1 ⋅ min−1) was twofold higher than net glycogenolysis, but comparable in T1Di and CON (3.7 ± 0.8 and 4.9 ± 1.0 μmol ⋅ kg−1 ⋅ min−1). Thus T1Dp exhibited glycogen cycling (3.5 ± 2.0 μmol ⋅ kg−1 ⋅ min−1), which accounted for 47% of GP flux.
CONCLUSIONS Poorly controlled T1D not only exhibits augmented fasting gluconeogenesis but also increased glycogen cycling. Intensified subcutaneous insulin treatment restores these abnormalities, indicating that hepatic glucose metabolism is not irreversibly altered even in longstanding T1D.
- Received July 7, 2010.
- Accepted March 28, 2011.
- © 2011 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.